Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

PARK WALL TECHNOLOGIES LTD

UEI: CB9BY59UEJ27CAGE: U2HF3

PARK WALL TECHNOLOGIES LTD is a federal contractor, registered under UEI CB9BY59UEJ27 and CAGE code U2HF3. It has been awarded $202,000 in federal contracts. Primary work spans Other Scientific and Technical Consulting Services. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

CB9BY59UEJ27

CAGE Code

U2HF3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

541690Other Scientific and Technical Consulting Services
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Park Wall Technologies Ltd specializes in advanced optical cardiovascular monitoring, focusing on the analysis and modeling of cardiovascular data. Their technical expertise centers on advancing robust monitoring capabilities through the application of photoplethysmography (PPG) and synchronous phot...

Park Wall Technologies Ltd specializes in advanced optical cardiovascular monitoring, focusing on the analysis and modeling of cardiovascular data. Their technical expertise centers on advancing robust monitoring capabilities through the application of photoplethysmography (PPG) and synchronous photoplethysmography (SPG) technologies. The company provides specialized scientific and technical consulting services to the Department of Health and Human Services and the National Institutes of Health (NIH), specifically supporting the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Their work for these agencies involves the development and refinement of optical monitoring models for cardiovascular health. Their industry focus is centered on other scientific and technical consulting services, specifically within the biomedical and healthcare research vertical. Park Wall Technologies Ltd is an entity structured as a 2L based in London.

Key Performance Metrics

Awards Count

1

All time

Active

1

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with PARK WALL TECHNOLOGIES LTD

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PARK WALL TECHNOLOGIES LTD

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PARK WALL TECHNOLOGIES LTD's top NAICS codes and agencies

NAICS: 541690
New
Federal
Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.
Solicitation # 7571PSQ00013
Solicitation 7571PSQ00013 is a competitive request for quote for an executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) for the NIH Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) and the HEAL Initiative. The selected contractor will act as a member of the External Oversight Committee (EOC), providing strategic guidance, programmatic reviews, and mentorship to advance the discovery and development of safe, non-addictive therapeutics for pain and nervous system conditions. The primary goal is to support the advancement of at least two novel therapeutics into clinical trials within five years. This is a small business set-aside under NAICS code 541690. The contract is structured as a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two optional one-year extensions, for a total potential duration of three years. The government anticipates approximately 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance will primarily occur at the contractor's site, with occasional visits to Bethesda, Maryland. Award decisions will be based on best value, with technical qualifications—specifically professional expertise in pharmaceutical development and pain, educational credentials, and collaborative experience—weighted significantly more than price and past performance. Proposed key personnel must be employees of the quoter by the start of performance and are subject to a salary cap based on the Executive Schedule, Level II. All quotes must be submitted by November 3, 2026, and require active registration in the System for Award Management.
Omas Strategic Buying Center - Professional Services

POSTED

about 24 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541690
New
Federal
Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network
Solicitation # 7571PS27Q00015
The Department of Health and Human Services, through the National Institute of Neurological Disorders and Stroke (NINDS), is soliciting a Firm Fixed Price purchase order for an executive-level Senior Advisor Subject Matter Expert (SME) with specialized expertise in Patient Advocacy. The selected contractor will serve on the Ultra-rare Gene-based Therapy (URGenT) External Counselor Board (ECB) to provide strategic guidance and technical feedback on drug discovery and development projects, specifically focusing on accelerating therapeutics for ultra-rare neurological diseases. Key responsibilities include recommending solutions for programmatic challenges, evaluating project milestones, and providing guidance on biologic drug discovery and gene-based therapy trials. The acquisition is a total set-aside for small business concerns under NAICS code 541690. The anticipated period of performance consists of a base year from November 6, 2026, to November 5, 2027, with two subsequent one-year options, totaling a maximum duration of three years. The government estimates a base effort of 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Awards will be based on best value, with technical qualifications regarding pharmaceutical development and pain expertise weighted significantly more than price and past performance. All quotes must be submitted by 1:00 PM Eastern Time on November 2, 2026, to the designated Contracting Officer.
Omas Strategic Buying Center - Professional Services

POSTED

about 24 hours ago

DEADLINE

in 5 days
View Details
NAICS: 541690
New
Federal
Senior Advisor 2 for the Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative to act as Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise
Solicitation # 7571PSQ00012
The National Institutes of Health (NIH) is seeking a highly experienced, executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) in Pharmacology and Pain for the Helping to End Addiction Long-term (HEAL) Initiative. The selected contractor will join the HEAL External Oversight Committee to provide strategic guidance, technical expertise on drug discovery and development projects, and mentorship to the HEAL executive team. Key responsibilities include reviewing program operations, recommending pharmacology-related trial advancements, and evaluating project milestones to accelerate the development of non-addictive analgesic therapeutics. This is a small business set-aside acquisition under NAICS code 541690, utilizing a fixed-price purchase order. The base period of performance is from November 5, 2026, to November 4, 2027, with two subsequent one-year option periods extending the total duration to three years. The government anticipates 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to $2,000 in annual travel expenses per consultant. Award will be based on best value, with technical qualifications—specifically professional experience in pharmaceutical development and pain expertise, educational credentials, and collaborative team experience—weighted as significantly more important than price and past performance. Applicants must be registered in the System for Award Management (SAM) and submit their quotes by 12:00 PM Eastern Time on November 3, 2026. Proposed key personnel must be employees of the quoter by the start of the contract and are subject to salary limitations based on the Executive Schedule, Level II.
Omas Strategic Buying Center - Professional Services

POSTED

about 24 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541690
New
Federal
Senior Advisor 2 Services for the NINDS Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative for the Pain Therapeutics Development Program (PTDP) External Oversight Committee (EOC) Subject Matter Expert (SME) Services
Solicitation # 7571PS27Q00011
The National Institutes of Health (NIH) is soliciting quotes for a highly experienced, executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) in Pharmacology and Pain. This role supports the NINDS Helping to End Addiction Long-term (HEAL) Initiative's Pain Therapeutics Development Program (PTDP) by serving on the External Oversight Committee (EOC). The selected contractor will provide strategic guidance, technical feedback on drug discovery and development projects, and mentorship to the HEAL executive team to accelerate the creation of non-addictive analgesic therapeutics. This acquisition is set aside for small business concerns under NAICS code 541690. The contract is structured as a fixed-price labor hour purchase order with a base period from November 5, 2026, to November 4, 2027, and two subsequent one-year options. The government anticipates an estimated 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance is primarily at the contractor's site, with occasional requirements at government facilities in Bethesda, Maryland. Evaluation will be based on best value, with technical qualifications weighted significantly more than price and past performance. The technical evaluation focuses on the SME's professional experience in pharmaceutical development, educational credentials, and collaborative team experience. Proposals must include resumes, letters of commitment, and a specific narrative demonstrating how personnel meet the qualifications. All quotes must be submitted by 12:00 PM Eastern Time on November 3, 2026, and offerors must be actively registered in the System for Award Management (SAM).
Omas Strategic Buying Center - Professional Services

POSTED

about 24 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541690
New
International
Air Simulator Verification, Validation & Accreditation (VV&A) consultants
Solicitation # W8485-26-SC20
The Department of National Defence is seeking two Air Simulator Verification, Validation and Accreditation (VV&A) consultants to support the Director Aerospace Equipment Program Management (Tactical Aviation and Simulation) group. These consultants will operate in an advisory capacity to independently determine flight simulator fitness and ensure compliance with technical and quality standards, including the Canadian Aviation Regulations. The work will be performed in the National Capital Region at 455 boul de la Carrière, Gatineau, QC. The contract is intended for an initial term of three years, starting December 1, 2026, with two irrevocable option years to extend the term. Each resource is estimated to work 240 days per year. The procurement will be awarded to the responsive bid with the lowest evaluated price per point. To be considered, bidders must meet mandatory technical criteria and achieve a minimum of 60 out of 100 points based on the resources' education, professional certifications, and at least 36 months of relevant VV&A experience within the last 84 months. Due to the nature of the work, the contractor must hold a Secret Facility Security Clearance and be registered in the Controlled Goods Program, while all personnel must be Canadian citizens with Secret security clearance. The contract includes strict operational limitations, prohibiting consultants from making official decisions, directing departmental organizations, or determining training policies on behalf of Canada.
Department of National Defence

POSTED

1 day ago

DEADLINE

in 29 days
View Details